XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Noncontrolling Interest [Member]
Treasury Stock, Common [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2023 $ 33,493,000 $ (25,915,000) $ 7,578,000
Balance, shares at Dec. 31, 2023 32,090          
Net loss (2,367,000) (2,367,000)
Stock-based compensation 19,000 19,000
Balance at Mar. 31, 2024 33,512,000 (28,282,000) 5,230,000
Balance, shares at Mar. 31, 2024 32,090          
Balance at Dec. 31, 2023 33,493,000 (25,915,000) 7,578,000
Balance, shares at Dec. 31, 2023 32,090          
Balance at Dec. 31, 2024 $ 5,000 39,682,000 (1,036,000) (49,172,000) (10,521,000)
Balance, shares at Dec. 31, 2024 470,825          
Net loss (103,000) (9,191,000) (9,294,000)
Exercise of Series B warrants $ 19,000 15,195,000 15,214,000
Exercise of Series B warrants, shares 1,910,975          
Stock-based compensation 85,000 85,000
Stock based compensation, shares 23,818          
Reclassification of Series A warrants to equity 7,857,000 7,857,000
Repurchase of common stock from related parties (758,000) 758,000
Repurchase of common stock from related parties, shares (10,990)          
Other
Other, shares 201          
Balance at Mar. 31, 2025 $ 24,000 $ 63,577,000 $ (1,139,000) $ (758,000) $ (58,363,000) $ 3,341,000
Balance, shares at Mar. 31, 2025 2,394,829